Deutsche Bank Ag\ Covetrus, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.69 - $20.91 $1.6 Million - $1.61 Million	77,124 Added 72.26%	183,853 $3.84 Million
Q2 2022 Aug 11, 2022	SELL	$13.8 - $20.82 $82,206 - $124,024	-5,957 Reduced 5.29%	106,729 $2.22 Million
Q1 2022 May 13, 2022	SELL	$15.96 - $18.87 $357,456 - $422,631	-22,397 Reduced 16.58%	112,686 $1.89 Million
Q4 2021 Feb 11, 2022	BUY	$16.79 - $20.37 $654,205 - $793,696	38,964 Added 40.54%	135,083 $2.7 Million
Q3 2021 Nov 04, 2021	SELL	$18.14 - $27.03 $32,978 - $49,140	-1,818 Reduced 1.86%	96,119 $1.74 Million
Q2 2021 Aug 11, 2021	SELL	$25.24 - $30.86 $268,225 - $327,949	-10,627 Reduced 9.79%	97,937 $2.64 Million
Q1 2021 May 13, 2021	SELL	$28.29 - $39.89 $77,967 - $109,936	-2,756 Reduced 2.48%	108,564 $3.25 Million
Q4 2020 Feb 16, 2021	BUY	$24.45 - $31.59 $764,991 - $988,387	31,288 Added 39.09%	111,320 $3.2 Million
Q3 2020 Nov 12, 2020	SELL	$17.22 - $24.59 $1.56 Million - $2.23 Million	-90,776 Reduced 53.15%	80,032 $1.95 Million
Q2 2020 Aug 13, 2020	SELL	$6.46 - $19.27 $505,940 - $1.51 Million	-78,319 Reduced 31.44%	170,808 $3.06 Million
Q1 2020 May 14, 2020	BUY	$5.64 - $15.23 $743,053 - $2.01 Million	131,747 Added 112.24%	249,127 $2.03 Million
Q4 2019 Feb 14, 2020	BUY	$8.8 - $14.93 $531,942 - $902,488	60,448 Added 106.18%	117,380 $1.55 Million
Q3 2019 Nov 14, 2019	SELL	$11.76 - $25.57 $2.17 Million - $4.71 Million	-184,120 Reduced 76.38%	56,932 $671,000
Q2 2019 Aug 14, 2019	BUY	$22.88 - $33.27 $671,756 - $976,807	29,360 Added 13.87%	241,052 $5.89 Million
Q1 2019 May 15, 2019	BUY	$31.52 - $46.19 $6.67 Million - $9.78 Million	211,692 New	211,692 $6.74 Million

Others Institutions Holding CVET

# of Institutions

Shares Held

72.9K

Call Options Held

Put Options Held

View Full List

About COVETRUS, INC.

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

More about CVET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account